期刊文献+

CD40用于肿瘤免疫治疗的研究进展 被引量:2

下载PDF
导出
出处 《肿瘤基础与临床》 2008年第5期455-457,共3页 journal of basic and clinical oncology
  • 相关文献

参考文献21

  • 1Smyth M J, Godfrey DI, Trapani JA. Afresh look at tumor immunosurveillance and Immunotherapy[ J ]. Nature Immunol, 2001, 24 (4) : 293 - 299.
  • 2Schonbeck U, Mach F, Libby P. CD154 (CD40 ligand) [J]. Int J Biochem Cell Biol,2000, 32 (7) : 687 - 693.
  • 3Young LS, Eliopoulos AG, Gallagher NJ, et al. CD40 and epithelial cells:across the great deride [ J]. Immunol Today, 1998,19 ( 11 ) : 502 - 506.
  • 4Costello RT, Gastaut JA, Olive D. What is the real role of CD40 in cancer immunotherapy? [ J]. Immunol Today, 1999,20( 11 ) : 488 - 493.
  • 5Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral protein: activation, costimulation, and death [ J ]. Cell, 1994,76(6) : 959 -962.
  • 6Phipps RP. Atherosclerosis: the emerging role of inflammation and the role CD40-D40 ligand system [ J]. Proc Natl Acad Sci U S A, 2000,97 ( 13 ) : 6930 - 6932.
  • 7DiSanto JP, Bonnefoy JY, Gauchat JF, et al. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM [ J]. Nature, 1993,361 (6412) :541 -543.
  • 8Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-D28 signaling through CD40 [ J ]. Science, 1996,273 (5283) :1862-1864.
  • 9Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell [J]. Nature, 1998, 393(6684): 474-478.
  • 10Bennett SR, Carbone FR, Karamalis F, et al. Help for cytotoxic-T- cell responses is mediated by CD40 signalling[ J]. Nature,1998,393 (6684) :478 -480.

二级参考文献1

  • 1关根知世子.巨噬细胞系的辅助分子[J].临床免疫(日),1996,28:68-74.

共引文献5

同被引文献21

  • 1阴晴,邵启祥,段秀杰,邹晓月,张瑞良,盛月华.类风湿关节炎患者血清sCD40L水平的变化及意义[J].山东医药,2008,48(20):30-31. 被引量:7
  • 2聆风.CD40蛋白能大幅提高肿瘤疫苗的功效[J].中华医学信息导报,2005,20(4):7-7. 被引量:1
  • 3庞雪芹,陈卫昌,李锐,岑建农.CD40配体激活抑制胃癌细胞生长机制的实验研究[J].苏州大学学报(医学版),2006,26(3):354-357. 被引量:3
  • 4邱莲女,周永列.CD40与肿瘤治疗研究进展[J].国际检验医学杂志,2006,27(11):1036-1038. 被引量:2
  • 5Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol. 1994;12:881-922.
  • 6Danese S, Scaldaferfi F, Vetrano S, et al. Critical role of the CD40 CD40-1igand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut. 2007;56(9): 1248-1256.
  • 7Prontera C, Martelli N, Evangelista V, et al. Homocysteine modulates the CD40/CD40L system. J Am Coil Cardiol. 2007; 49(22): 2182-2190.
  • 8Zirlik A, Maier C, Gerdes N, et al. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation. 2007;115(12):1571-1580.
  • 9Dranitzki-Elhalel M, Huang JH, Sasson M, et al. CD40.FasL inhibits human T ceils: evidence for an auto-inhibitory loop-back mechanism. Int Immunol. 2007;19(4):355-363.
  • 10Hammwohner M, Ittenson A, Dierkes J, et al. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med (Maywood). 2007;232(4):581-589.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部